Objective-To determine the impact of hematopoietic deletion of nuclear factor− (erythroid-derived 2) like 2 factor (Nrf2) on the development of atherosclerosis and liver injury in an obese, hypercholesterolemic mouse model. Methods and Results-Two-month-old male low-density lipoprotein receptor-deficient mice were lethally irradiated and transplanted with either wild type or Nrf2-deficient (Nrf2
O xidative stress induced by aging, metabolic disease, and obesity is a key mechanism of tissue injury. Middle-aged (12-month-old) low-density lipoprotein receptor-deficient (Ldlr −/− ) male mice develop both advanced atherosclerosis and all components of nonalcoholic steatohepatitis (NASH) when fed high-fat diet (HFD). 1, 2 Atherosclerosis and NASH developed in parallel in these mice, similar to humans with metabolic syndrome. 3 Both complications were associated with marked tissue deficits in nuclear factor-(erythroid-derived 2) like 2 factor (Nrf2), a major transcriptional regulator of multiple antioxidant and detoxification enzymes. 1, 2 Loss of Nrf2 and antioxidant activity was implicated in atherosclerosis and NASH development, because oxidative stress is a known mediator of both pathologies.
Subsequent vascular studies of Nrf2 in animal models have been inconsistent. Mice with whole-body Nrf2 deletion demonstrated greater endothelial dysfunction compared with wild-type (WT) mice in response to HFD. 4 Vascular upregulation of Nrf2 and its target genes in response to high glucose and H 2 O 2 was also blunted in aged rats and macaques, leading to increased vascular oxidative damage. 5, 6 These data indicate a critical role of Nrf2 in vascular injury. However, whole-body Nrf2 deletion in a nonobese mouse model of atherosclerosis, the apolipoprotein E-deficient mice, resulted in decreased atherosclerosis. 7 This was attributed to altered liver and plasma cholesterol, decreased macrophage CD36, and decreased inflammasome activation resulting from systemic effects of Nrf2. 7, 8 By contrast, several investigations demonstrated that Nrf2 knockout markedly accelerated liver damage in response to HFD and other toxins. 9 ,10 HFD-induced steatosis was associated with increased mitochondrial superoxide production 2, 11, 12 and in some models, hepatic Nrf2 activity losses. 2, 9, 13 Indeed, HFD-fed Nrf2 −/− mice had more hepatic lipid and oxidative stress than WT mice and, when fed methionine-cholinedeficient diet to induce NASH, a marked increase in inflammation. 9, 10, 14 However, although informative, these studies did not address how Nrf2 loss in specific cell populations impacts liver injury.
Myeloid lineage cells differentiate into foam cells, which make up the cores of atherosclerotic lesions and Kupffer cells, which play a major role in NASH development. 15, 16 We, thus, hypothesize that Nrf2 deficiency in macrophages would lead to increased vascular and liver damage. To determine the role of hematopoietic Nrf2 in these processes, we transplanted bone marrow from Nrf2 −/− mice into middle-aged male Ldlr −/− mice to generate mice with myeloid-specific Nrf2 deficiency. Our results indicate that myeloid Nrf2 deficiency accelerates both atherosclerosis and NASH development.
Materials and Methods

Animals, Diets, and Bone Marrow Transplantation
C57BL/6 background Ldlr −/− mice (Jackson Laboratory, #002207, Bar Harbor, ME) and Nrf2 −/− mice (kind gift from Jeff Chan, University of California, Irvine, CA) were group housed under 12 hours light/12 hours dark and fed standard chow (8904, Harlan Teklad, Madison, WI). Baytril-treated mice aged 2 months were irradiated with 9 Gy using a 137 Cs irradiator and 4 to 8 hours later injected with 4 million bone marrow cells from WT (C57BL/6J) or Nrf2 −/− to generate WT and Nrf2 −/− bone marrow transplant (BMT) mice. After 4 weeks, BMT mice were continued on chow or fed HFD (RD Western D12079B, Research Diets, New Brunswick, NJ; described in Table I in the online-only Data Supplement). After 7 months on diet, mice were weighed and analyzed for body composition, then sacrificed by CO 2 overdose for assessment of en face atherosclerosis and liver histology as previously described. 17 Thoracic aortae and liver samples for gene expression studies were collected from a second set of mice. All animal experiments were approved by The Methodist Hospital Research Institute Institutional Animal Care and Use Committees and complied with all federal, state, and local regulations and policies.
Cell Culture Experiments
Bone marrow for BMT and culture studies was collected from mouse femurs and tibia by syringe perfusion. Cells were cultured for 7 days in bone marrow-derived macrophage (BMDM) differentiation medium (DMEM, 20% fetal bovine serum, and 30% L929-cell conditioned medium) at 37°C in 5% CO 2 and then assayed using the QCM Chemotaxis Cell Migration Assay, Fluorometric (ECM507, Chemicon International, Billerica, MA) according to the manufacturer's instructions. For apoptosis assays, BMDMs were treated with 0, 1, 10, and 100 μmol/L H 2 O 2 for 16 hours and caspase 3/7 activity was measured using ApoTox-Glo Triplex Assay Kits (Promega Corporation, Madison, WI). Peritoneal macrophage (PM) were isolated as previously described, 18 lipopolysaccharide (LPS; 100 ng/mL) stimulated for 20 hours in RPMI 1640 media with 10% fetal bovine serum, and then harvested for RNA isolation.
Gene Expression
RNA was isolated using RNeasy kits (QIAGEN), reverse-transcribed with High-Capacity cDNA Reverse Transcription Kits (Applied Biosystems, Carlsbad, CA), and amplified with Taqman PCR Core Reagent Kits and gene-specific primer/probe sets (Applied Biosystems), with expression values normalized to sample Ppia (Cyclophilin A) expression.
Protein Analyses
Peripheral blood mononuclear cells were isolated from 6 WT and 6 Nrf2 −/− BMT mice, by red blood cell lysis, and processed for protein. peripheral blood mononuclear cells western blots were probed with antibodies for catalase (Abcam, Cambridge, MA) and β-actin (Santa Cruz Biotechnology) as a loading control and analyzed by densitometry using National Institutes of Health Image1.60 software.
Histology
En face atherosclerosis was analyzed as previously described. 1 After atherosclerosis quantification, Sudan IV-stained vessels were destained in 80% ethanol, embedded in paraffin, sectioned, and stained to determine lesion complexity and composition by light microscopy with hematoxylin/eosin or immunofluorescence microscopy. Necrotic lipid cores (NLC) were quantified by light microscopy in 10 μm-serial sections obtained from the aortic arch and stained with hematoxylin/eosin. 19 The area of lesion was defined by the internal elastic lamina and the luminal boundary, and data were calculated as percent NLCs in total lesion area in the sections quantified. 20 Formalin-fixed liver tissue was stained with Masson Trichrome to detect collagen or hematoxylin/eosin for contrast. Steatosis, fibrosis, inflammation, and hepatocyte ballooning were assayed according to the NASH diagnosis guidelines of Kleiner et al. 21 Vessels were paraffin-embedded for hematoxylin/eosin or dual immunofluorescence staining with F4/80 antibody (eBioscience, San Diego, CA) and Alexa Fluor 647-conjugated secondary antibody (Life Technologies, Carlsbad, CA), and Nrf2 antibody (Santa Cruz Biotechnology) and Alexa Fluor 555-cojugated secondary antibody (Invitrogen, Grand Island, NY). Immunofluorescent images were obtained at 600X magnification using a Nikon A1 confocal microscope and NIS-Elements Microscope Imaging Software.
Plasma Metabolite Analyses
Blood glucose levels were determined using OneTouch (Johnson and Johnson, Milpitas, CA) and plasma insulin was determined by ELISA (Rat/Mouse Insulin ELISA, Millipore, Billerica, MA). Sample aliquots were sent to the Mouse Metabolic Phenotyping Center at the University of Cincinnati for determination of plasma lipids, alanine amino transferase, and aspartate amino transferase levels.
Statistics
Mann-Whitney nonparametric analyses were employed to identify differences for the following pairwise group comparisons: Chowfed WT versus Nrf2 WT BMT-recipient Ldlr −/− mice demonstrated no gross phenotypic differences. Both groups gained similar body weight, body fat percentage, and liver fat and had similar increases in glucose, insulin, and plasma lipids (total cholesterol, triglycerides, and phospholipids) when fed HFD (Table) , similar to previously published Ldlr −/− mouse dietary responses. 1, 22 White blood cell abundance and diversity were not different in Nrf2
−/− and WT BMT mice (Table II in 
Vessels of HFD-Fed Nrf2 −/− BMT Mice Have Reduced Antioxidant Genes and Increased Proinflammatory Genes
Vascular expression of Nrf2 and several Nrf2-regulated antioxidant enzymes, including NAD(P)H dehydrogenase, quinone 1 (Nqo1), catalase (Cat) and glutathione peroxidase 1 (Gpx1), were decreased in HFD-fed Nrf2 −/− versus WT BMT mice ( Figure 3A) , with trends for decreased Gpx4 and glutathione S-transferase alpha 2 (Gsta2). Other Nrf2 target genes, such as superoxide dismutase 2 (Sod2), heme oxygenase 1 (Hmox1), and thioredoxin reductase (Txnrd1), were not different (data not shown), suggesting differential macrophage contributions to vascular antioxidant enzyme expression. Vascular expression of Park7, which protects Nrf2 from degradation, and MafG and MafK, Nrf2 transcriptional partners, were also not different (data not shown). HFD also increased vascular expression of multiple proinflammatory genes more in Nrf2 −/− BMT vs. WT BMT mice ( Figure 3B Figure 3B ). Cd68 expression, a marker of macrophage accumulation, increased with HFD but was not different between HFDfed Nrf2 −/− BMT vs. WT BMT mice, nor was vascular expression of Cd36, a major cholesterol uptake protein implicated in previous Nrf2 studies ( Figure 3C ). This general decrease in antioxidant enzyme expression coupled with increased proinflammatory cytokine expression, could contribute to the increased atherosclerotic phenotype of HFD-fed Nrf2 −/− BMT vs. WT BMT mice.
Myeloid Nrf2 Deficiency Increases HFDInduced Liver Inflammation and Fibrosis
HFD-fed Nrf2 −/− BMT and WT BMT Ldlr −/− mice developed similar amounts of liver fat assessed by nuclear magnetic resonance (Table) . Although ballooning degeneration was similar, −/− BMT mice, however, exhibited a trend towards increased inflammatory cell foci (Figures 4A and 4C ; P=0.11), and more fibrosis than WT BMT mice ( Figure 4B and 4D ), in agreement with a trend toward increased blood transaminase levels ( Figure 4E ) suggestive of greater liver injury in HFDfed Nrf2 −/− BMT mice. Livers of HFD-fed Nrf2 −/− BMT mice also displayed significantly more expression of several proinflammatory marker genes (Cd68, Opn, Il1b and Tnf) compared to WT BMT mice ( Figure 4F ). In agreement with histological fibrosis results, Nrf2 −/− BMT mice also revealed increased hepatic expression of the profibrotic cytokine transforming growth factor β1 (Tgfb1) as well as several fibrotic proteins, including type 1 and 4 collagens (Col1a2 and Col4a1) and fibronectin (Fbn) ( Figure 4G ). There were no differences in expression of hepatic Cd36, 3-hydroxy-3-methylglutarylcoenzyme A reductase, or other lipid metabolism genes (data not shown).
Discussion
This investigation provides evidence that myeloid Nrf2 deficiency enhances both HFD-induced atherosclerosis area and complexity, and liver inflammation and fibrosis. Enhanced atherosclerosis development and liver injury in this study are likely mediated by increased migration, inflammation, and oxidative stress responses of Nrf2-deficient inflammatory cells. These results strongly suggest that Nrf2 activity in macrophages, Kupffer cells and perhaps in other myeloid lineage cell types plays an important role in the attenuation of these 2 common obesity-associated pathologies. Taken together, these results may have therapeutic implications to ameliorate vascular and liver complications of metabolic syndrome driven by inflammation and oxidative stress.
Macrophages are critical mediators of atherosclerosis that take up oxidized cholesterol in the vessel wall to form foam cells, whose subsequent deaths lead to NLC formation. The dynamics of NLC formation and resolution are major determinants of atherosclerosis extent and lesion complexity. Reducing macrophage apoptosis, by deletion of the proapoptotic factor C/EBP homologous protein 23, 24 or by deletion of Stat1 to prevent endoplasmic reticulum stress, attenuates plaque necrosis. 25 Conversely, changes that promote apoptosis, including deletion of the insulin receptor or Bcl-2, even early in the atherosclerotic process, increase NLC formation and lesion complexity. 26, 27 We previously showed that HFD-fed young Ldlr −/− that develop fatty streaks have increased vascular expression of Nrf2-regulated antioxidant genes, whereas HFDfed middle-aged Ldlr −/− mice that develop advanced lesions have decreased vascular Nrf2 expression corresponding to the onset of NLC development, suggesting that vascular oxidative stress promotes the observed NLC formation. 1 Our current results link macrophage Nrf2 deficiency with increased foam cell death, a major cause of NLC formation. We find that Nrf2-deficient macrophages have increased apoptosis in response to H 2 O 2 -induced oxidative stress, consistent with a report that cells from Nrf2 −/− mice have an impaired antioxidant response, decreased expression of prosurvival factors, and increased apoptosis and decreased survival when exposed to oxidative stress 28 and electronegative LDL, 29 despite no differences in basal levels of reactive oxygen species in Nrf2-deficient cells. Similarly, in a mouse emphysema model, Nrf2 −/− mice receiving WT BMTs had improved pulmonary function and decreased apoptosis of their alveolar macrophages. 30 Several reports, thus, indicate that Nrf2 deficiency is associated with enhanced macrophage apoptosis to oxidative stress.
We and others have shown that impairment of macrophage migration and proinflammatory responses decreases atherosclerosis. [31] [32] [33] Enhanced macrophage migration and inflammation may contribute to increased atherosclerosis in Nrf2 −/− BMT mice. Vascular expression of the macrophage chemoattractant 
LPS-treated Nrf2
−/− macrophages also expressed more MCP-1 than WT macrophages, without a corresponding downregulation of the MCP-1 receptor C-C chemokine receptor type 2, indicating that Nrf2 −/− macrophages may be both more chemoattractive and responsive to migration factors than WT macrophages, as observed in our in vitro studies. Cellular oxidative stress generates H 2 O 2 , which promotes cell migration; thus, reduced antioxidant responses are implicated in cell movement. 34 Nrf2 −/− BMT mice have reduced expression of several antioxidant genes in response to HFD, including catalase, which can attenuate vascular injury. In Apoe −/− mice, catalase overexpression reduced atherosclerosis and was associated with both decreased vascular oxidative stress and reduced acellular area in aortic sinus lesions, indicative of decreased macrophage death. 35 Catalase overexpression is also associated with decreased vascular macrophage accumulation in a hindlimb ischemia model and with impaired MCP-1-directed macrophage migration in vitro. 36 Other studies have demonstrated that Nrf2 affects the migration of multiple cancer cell types and leukocytes in arthritis. 37, 38 Our atherosclerosis results differ from those reported for Apoe −/− Nrf2 −/− mice, which developed less atherosclerosis than Apoe −/− mice. 7, 8, 39 This difference likely results from the mouse models. Ldlr −/− mice require HFD to develop the hypercholesterolemia required to drive atherosclerosis. However, HFD also induces central adiposity and metabolic syndrome, and obesity-associated oxidative stress may drive target organ damage in Ldlr −/− mice. Apoe −/− mice develop spontaneous hypercholesterolemia in the absence of HFD and do not become grossly obese even when fed HFD. 40 Indeed, apolipoprotein E overexpression is reported to induce metabolic syndrome.
41
Nrf2 may also be differentially regulated in Apoe −/− and Ldlr −/− mice, because apolipoprotein E has been reported to decrease hepatic Nrf2 expression, 42 whereas differences between wholebody and bone marrow Nrf2 deficiency may also contribute to phenotype differences. For example, 1 study found that Apoe −/− Nrf2 −/− mice have decreased plasma and liver cholesterol, which was proposed to partially account for the decreased atherosclerosis in these mice. 7 We did not observe significant differences in plasma cholesterol, triglycerides, or phospholipids in our Nrf2 −/− BMT Ldlr −/− mice, suggesting that hepatocyte Nrf2 deficiency contributes to these lipid changes. Another study found smaller plaques in Apoe −/− Nrf2 −/− mice, which were associated with decreased uptake of modified LDL by isolated 44 Kupffer cells, specialized liver macrophages, are key drivers of liver inflammation. 42 Despite similar fat content, livers of HFD-fed Nrf2 −/− versus WT BMT mice revealed a trend toward more inflammatory cell foci coupled with significantly increased expression of CD68 and several proinflammatory genes. These changes were accompanied by a 2-fold increase in fibrosis and increased expression of fibrosis genes, consistent with evidence that hepatic inflammation leads to fibrosis. 45 Steatosis is proposed as the first hit in fatty liver disease, whereas oxidative stress represents a second hit that promotes progression from nonalcoholic fatty liver disease to NASH, characterized by inflammation and fibrosis. 46 Stellate cells, the primary source of liver collagen, are quiescent under normal conditions but can become activated, proliferate, and increase collagen production in response to inflammation and oxidative stress. Thus, it appears likely that increased HFD-induced liver inflammation, resulting from Nrf2 deletion in Kupffer cells and invading macrophages, may activate stellate cells. Nrf2 activation has been reported to inhibit α-smooth muscle actin and transforming growth factor-1β expression and function in a mouse liver fibrosis model, 47 further suggesting that Nrf2 activity plays an important role in the attenuation of liver fibrosis. Meher et al 48 showed that myeloid Nrf2 deficiency is not sufficient to protect mice from HFD-induced insulin resistance, consistent with our findings that insulin or glucose levels were not different between WT BMT and Nrf2 −/− BMT mice (Table) . However in their study, Nrf2 −/− BMT mice had less weight gain and fat mass with HFD, which may be responsible for their lack of effects of myeloid Nrf2-blation on adipose tissue inflammation. 48 In summary, we observed that the loss of antioxidant responses in hematopoietic cells leads to increased macrophage migration, inflammation, and oxidative stress. These proinflammatory changes likely contributed to NLC formation and accelerated atherosclerosis and to accelerated hepatic fibrosis, both of which are highly uncommon in obese mouse models. This escalation of 2 major pathologies in HFD-fed Nrf2 −/− BMT mice underscores the importance of Nrf2 to protect tissues from leukocyte-mediated inflammatory responses in the face of overwhelming oxidative stress. Taken together these data indicate that loss of Nrf2 in inflammatory cells increases the severity of common obesity-associated complications, such as NASH and atherosclerosis, and that treatments designed to enhance intracellular antioxidant pathways specifically in inflammatory cells might have beneficial effects in this setting.
